{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T11:51:07Z","timestamp":1782042667201,"version":"3.54.5"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["R01CA252185"],"award-info":[{"award-number":["R01CA252185"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2024\/13400-1"],"award-info":[{"award-number":["2024\/13400-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2022\/02062-2"],"award-info":[{"award-number":["2022\/02062-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cct.2025.108189","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:02:13Z","timestamp":1766160133000},"page":"108189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The Pharmaceutically Enhanced Reinforcement for Reduced Alcohol and Smoking (PERRAS) Study: Protocol for a randomized clinical trial"],"prefix":"10.1016","volume":"161","author":[{"given":"Paola","family":"Palombo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Akana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Hovland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Connor","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Rodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Chaytor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"McDonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Burduli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Roll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Q.","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling M.","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cct.2025.108189_bb0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/add.13099","article-title":"An international systematic review of smoking prevalence in addiction treatment","volume":"111","author":"Guydish","year":"2016","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.cct.2025.108189_bb0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cpr.2009.08.009","article-title":"Addressing tobacco use disorder in smokers in early remission from alcohol dependence: The case for integrating smoking cessation services in substance use disorder treatment programs","volume":"30","author":"Kalman","year":"2010","journal-title":"Clin. Psychol. Rev."},{"issue":"13","key":"10.1016\/j.cct.2025.108189_bb0015","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/cncr.28695","article-title":"The 2014 Surgeon General\u2019s report: \u201cThe Health Consequences of Smoking\u201350 Years of Progress\u201d: A paradigm shift in cancer care","volume":"120","author":"Warren","year":"2014","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.cct.2025.108189_bb0020","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.1996.03530380039029","article-title":"Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort","volume":"275","author":"Hurt","year":"1996","journal-title":"JAMA: J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.cct.2025.108189_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopsych.2006.11.004","article-title":"The biological bases of nicotine and alcohol Co-addiction","volume":"61","author":"Li","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"9752","key":"10.1016\/j.cct.2025.108189_bb0030","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(10)61462-6","article-title":"Drug harms in the UK: a multicriteria decision analysis","volume":"376","author":"Nutt","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cct.2025.108189_bb0035","first-page":"193","article-title":"Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver","volume":"29","author":"Pelucchi","year":"2006","journal-title":"Alcohol. Res. Health."},{"issue":"1","key":"10.1016\/j.cct.2025.108189_bb0040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/add.14008","article-title":"Effects of high alcohol intake, alcohol-related symptoms and smoking on mortality","volume":"113","author":"Whitfield","year":"2018","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.cct.2025.108189_bb0045","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.addbeh.2004.06.014","article-title":"Topiramate-induced neuromodulation of cortico\u2013mesolimbic dopamine function: A new vista for the treatment of comorbid alcohol and nicotine dependence?","volume":"29","author":"Johnson","year":"2004","journal-title":"Addict. Behav."},{"key":"10.1016\/j.cct.2025.108189_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2018.08.007","article-title":"Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50\u00a0years","volume":"836","author":"Blanco-Gand\u00eda","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.cct.2025.108189_bb0055","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drugalcdep.2008.10.006","article-title":"Alcohol consumption and quitting smoking in the International Tobacco Control (ITC) four country survey","volume":"100","author":"Kahler","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.cct.2025.108189_bb0060","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/ntr\/ntq083","article-title":"Alcohol use and initial smoking lapses among heavy drinkers in smoking cessation treatment","volume":"12","author":"Kahler","year":"2010","journal-title":"Nicotine Tobacco Res."},{"issue":"6","key":"10.1016\/j.cct.2025.108189_bb0065","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1037\/a0029931","article-title":"Relations of alcohol consumption with smoking cessation milestones and tobacco dependence","volume":"80","author":"Cook","year":"2012","journal-title":"J Consult Clin Psychol."},{"issue":"3","key":"10.1016\/j.cct.2025.108189_bb0070","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/alcalc\/agm022","article-title":"Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review","volume":"42","author":"Leeman","year":"2007","journal-title":"Alcohol Alcoholism."},{"issue":"12","key":"10.1016\/j.cct.2025.108189_bb0075","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1080\/14622200802443742","article-title":"Risk factors for treatment failure in smokers: Relationship to alcohol use and to lifetime history of an alcohol use disorder","volume":"10","author":"Leeman","year":"2008","journal-title":"Nicotine Tobacco Res."},{"issue":"5","key":"10.1016\/j.cct.2025.108189_bb0080","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/FBP.0000000000000379","article-title":"Pilot investigation: randomized-controlled analog trial for alcohol and tobacco smoking co-addiction using contingency management","volume":"29","author":"Orr","year":"2018","journal-title":"Behav. Pharmacol."},{"issue":"11","key":"10.1016\/j.cct.2025.108189_bb0085","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/acer.12854","article-title":"Varenicline for treatment of alcohol dependence: a randomized","volume":"39","author":"de Bejczy","year":"2015","journal-title":"Placebo-Controlled Trial. Alcohol Clin Exp Res."},{"issue":"6","key":"10.1016\/j.cct.2025.108189_bb0090","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1530-0277.2009.00925.x","article-title":"Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study","volume":"33","author":"King","year":"2009","journal-title":"Alcohol Clin Exp Res."},{"issue":"05","key":"10.1016\/j.cct.2025.108189_bb0095","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S146114570800936X","article-title":"Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation","volume":"12","author":"O\u2019Malley","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.cct.2025.108189_bb0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/jsc.2020.13","article-title":"An integrated behavioral intervention combined with varenicline for heavy-drinking smokers: a randomized pilot study","volume":"15","author":"Fucito","year":"2020","journal-title":"J. Smok. Cessat."},{"issue":"11","key":"10.1016\/j.cct.2025.108189_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14594","article-title":"The effects of pharmacological interventions on smoking cessation in people with alcohol dependence: A systematic review and meta-analysis of nine randomized controlled trials","volume":"75","author":"Guo","year":"2021","journal-title":"Int. J. Clin. Pract."},{"issue":"4","key":"10.1016\/j.cct.2025.108189_bb0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/ADM.0b013e31829623f4","article-title":"A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence","volume":"7","author":"Litten","year":"2013","journal-title":"J. Addict. Med."},{"issue":"4","key":"10.1016\/j.cct.2025.108189_bb0115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/JCP.0000000000001864","article-title":"Combination treatment with varenicline and nicotine patch on smoking cessation outcomes in heavy drinkers at 26-week follow-up","volume":"44","author":"Robinson","year":"2024","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cct.2025.108189_bb0120","author":"World Health Organization (WHO)"},{"issue":"3","key":"10.1016\/j.cct.2025.108189_bb0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2020.25019","article-title":"Interventions for Tobacco smoking cessation in adults, including pregnant persons","volume":"325","author":"Krist","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2025.108189_bb0130","first-page":"14","article-title":"A randomized controlled trial of varenicline and brief behavioral counseling delivered by lay counselors for adolescent vaping cessation: Study protocol","author":"Schuster","year":"2023","journal-title":"Front. Psychiatry."},{"issue":"5","key":"10.1016\/j.cct.2025.108189_bb0135","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/acer.13994","article-title":"Longitudinal findings from a randomized clinical trial of varenicline for alcohol use disorder with comorbid cigarette smoking","volume":"43","author":"Bold","year":"2019","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.cct.2025.108189_bb0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2017.11.017","article-title":"Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial","volume":"184","author":"Hurt","year":"2018","journal-title":"Drug Alcohol. Depend."},{"key":"10.1016\/j.cct.2025.108189_bb0145","first-page":"38","article-title":"Manejo de Conting\u00eancia Aplicado ao Transtorno por Uso de \u00c1lcool: Revis\u00e3o Sistem\u00e1tica","author":"de Silva","year":"2022","journal-title":"Psicologia: Teoria e Pesquisa."},{"issue":"1","key":"10.1016\/j.cct.2025.108189_bb0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1901\/jaba.2012.45-161","article-title":"Voucher-based reinforcement for alcohol abstinence using the ethyl-glucuronide alcohol biomarker","volume":"45","author":"Mcdonell","year":"2012","journal-title":"J. Appl. Behav. Anal."},{"key":"10.1016\/j.cct.2025.108189_bb0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cct.2018.04.010","article-title":"Using a randomized controlled trial to test whether modifications to contingency management improve outcomes for heavy drinkers with serious mental illness","volume":"69","author":"Oluwoye","year":"2018","journal-title":"Contemp. Clin. Trials"},{"issue":"6","key":"10.1016\/j.cct.2025.108189_bb0160","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/1740774518796151","article-title":"Contingency management intervention targeting co-addiction of alcohol and drugs among American Indian adults: Design, methodology, and baseline data","volume":"15","author":"Burduli","year":"2018","journal-title":"Clin. Trials."},{"issue":"4","key":"10.1016\/j.cct.2025.108189_bb0165","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1521-0391.2013.12114.x","article-title":"Preliminary findings: Contingency management targeting psycho-stimulant use results in secondary decreases in smoking for severely mentally ill adults","volume":"23","author":"McDonell","year":"2014","journal-title":"Am. J. Addict."},{"issue":"4","key":"10.1016\/j.cct.2025.108189_bb0170","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1176\/appi.ajp.2016.16050627","article-title":"A randomized controlled trial of ethyl glucuronide-based contingency management for outpatients with co-occurring alcohol use disorders and serious mental illness","volume":"174","author":"McDonell","year":"2017","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.cct.2025.108189_bb0175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/jamapsychiatry.2020.4768","article-title":"Effect of incentives for alcohol abstinence in partnership With 3 American Indian and Alaska native communities","volume":"78","author":"McDonell","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.cct.2025.108189_bb0180","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/add.15349","article-title":"The rewarding recovery study: a randomized controlled trial of incentives for alcohol and drug abstinence with a rural American Indian community","volume":"116","author":"McDonell","year":"2021","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.cct.2025.108189_bb0185","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1360-0443.2006.01581.x","article-title":"Contingency management for treatment of substance use disorders: a meta-analysis","volume":"101","author":"Prendergast","year":"2006","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.cct.2025.108189_bb0190","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1037\/0022-006X.68.2.250","article-title":"Give them prizes and they will come: Contingency management for treatment of alcohol dependence","volume":"68","author":"Petry","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"issue":"4","key":"10.1016\/j.cct.2025.108189_bb0195","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s12529-023-10197-8","article-title":"A systematic review of the efficacy of contingency management for substance use disorders in low and middle income countries","volume":"31","author":"Kalmin","year":"2024","journal-title":"Int. J. Behav. Med."},{"key":"10.1016\/j.cct.2025.108189_bb0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/SAR.S138439","article-title":"A review of contingency management for the treatment of substance-use disorders: adaptation for underserved populations, use of experimental technologies, and personalized optimization strategies","volume":"9","author":"McPherson","year":"2018","journal-title":"Subst Abuse Rehabil."},{"issue":"3","key":"10.1016\/j.cct.2025.108189_bb0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.biopsych.2015.10.024","article-title":"Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders","volume":"80","author":"Kwako","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.cct.2025.108189_bb0210","first-page":"8","article-title":"Commentary: addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders","author":"Ghitza","year":"2017","journal-title":"Front. Psychiatry."},{"key":"10.1016\/j.cct.2025.108189_bb0215","doi-asserted-by":"crossref","DOI":"10.1177\/2470547017698140","article-title":"Neuroclinical framework for the role of stress in addiction","volume":"1","author":"Kwako","year":"2017","journal-title":"Chronic Stress."},{"issue":"7","key":"10.1016\/j.cct.2025.108189_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2016.08.029","article-title":"Reply to: neuroclinical assessment of addiction needs to incorporate decision-making measures and ecological validity","volume":"81","author":"Kwako","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.cct.2025.108189_bb0225","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/archgenpsychiatry.2010.190","article-title":"Effects of varenicline on smoking cue\u2013triggered neural and craving responses","volume":"68","author":"Franklin","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.cct.2025.108189_bb0230","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.biopsych.2008.08.028","article-title":"Varenicline improves mood and cognition during smoking abstinence","volume":"65","author":"Patterson","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2025.108189_bb0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1037\/pha0000161","article-title":"Effects of varenicline on cognitive performance in heavy drinkers: Dose-response effects and associations with drinking outcomes","volume":"26","author":"Roberts","year":"2018","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.cct.2025.108189_bb0240","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/FBP.0000000000000349","article-title":"Decreases in smoking during treatment for methamphetamine-use disorders: preliminary evidence","volume":"29","author":"McPherson","year":"2018","journal-title":"Behav. Pharmacol."},{"issue":"4","key":"10.1016\/j.cct.2025.108189_bb0245","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00213-010-2160-9","article-title":"A preliminary investigation of varenicline for heavy drinking smokers","volume":"215","author":"Fucito","year":"2011","journal-title":"Psychopharmacol. (Berl)."},{"issue":"15","key":"10.1016\/j.cct.2025.108189_bb0250","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.166.15.1561","article-title":"Smoking cessation with varenicline, a selective \u03b14\u03b22 nicotinic receptor partial agonist","volume":"166","author":"Nides","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.cct.2025.108189_bb0255","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1185\/030079907X182185","article-title":"A double-blind study evaluating the long-term safety of varenicline for smoking cessation","volume":"23","author":"Williams","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"issue":"5","key":"10.1016\/j.cct.2025.108189_bb0260","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1521-0391.2013.12037.x","article-title":"Varenicline and neuronal nicotinic acetylcholine receptors: A new approach to the treatment of co-occurring alcohol and nicotine addiction?","volume":"22","author":"Nocente","year":"2013","journal-title":"Am. J. Addict."},{"issue":"1","key":"10.1016\/j.cct.2025.108189_bb0265","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1176\/appi.ajp.2012.11121831","article-title":"Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness","volume":"170","author":"McDonell","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.cct.2025.108189_bb0270","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1037\/a0027802","article-title":"Investigating reinforcer magnitude and reinforcer delay: A contingency management analog study","volume":"20","author":"Packer","year":"2012","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.cct.2025.108189_bb0275","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1521-0391.2013.12059.x","article-title":"Biochemical marker of use is a better predictor of outcomes than self-report metrics in a contingency management smoking cessation analog study","volume":"23","author":"McPherson","year":"2014","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.cct.2025.108189_bb0280","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.drugalcdep.2015.10.004","article-title":"Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients","volume":"157","author":"McDonell","year":"2015","journal-title":"Drug Alcohol. Depend."},{"issue":"6","key":"10.1016\/j.cct.2025.108189_bb0285","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/add.13767","article-title":"A preliminary randomized controlled trial of contingency management for alcohol use reduction using a transdermal alcohol sensor","volume":"112","author":"Barnett","year":"2017","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.cct.2025.108189_bb0290","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0376-8716(03)00032-2","article-title":"Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients","volume":"70","author":"Kosten","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"11_supplement_3","key":"10.1016\/j.cct.2025.108189_bb0295","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3182872ded","article-title":"Cognition assessment using the NIH toolbox","volume":"80","author":"Weintraub","year":"2013","journal-title":"Neurology"},{"issue":"11_supplement_3","key":"10.1016\/j.cct.2025.108189_bb0300","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3182872e11","article-title":"Emotion assessment using the NIH Toolbox","volume":"80","author":"Salsman","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.cct.2025.108189_bb0305","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addbeh.2016.02.035","article-title":"Additional validity evidence for the PROMIS smoking assessment toolkit","volume":"58","author":"Edelen","year":"2016","journal-title":"Addict. Behav."},{"issue":"3","key":"10.1016\/j.cct.2025.108189_bb0310","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ntr\/ntv083","article-title":"The psychometric performance of the PROMIS smoking assessment toolkit: comparisons of real-data computer adaptive tests, short forms, and mode of administration","volume":"18","author":"Stucky","year":"2016","journal-title":"Nicotine Tobacco Res."},{"issue":"1","key":"10.1016\/j.cct.2025.108189_bb0315","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.psychres.2012.09.034","article-title":"Assessment of self-reported negative affect in the NIH Toolbox","volume":"206","author":"Pilkonis","year":"2013","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.cct.2025.108189_bb0320","first-page":"108","article-title":"Validity of the Obsessive Compulsive Drinking Scale (OCDS): does craving predict drinking behavior?","volume":"23","author":"Kranzler","year":"1999","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"8","key":"10.1016\/j.cct.2025.108189_bb0325","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1530-0277.2006.00159.x","article-title":"Factor structure of the alcohol urge questionnaire under neutral conditions and during a cue-elicited urge state","volume":"30","author":"MacKillop","year":"2006","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.cct.2025.108189_bb0330","doi-asserted-by":"crossref","first-page":"326","DOI":"10.15288\/jsad.2015.76.326","article-title":"A daily measure of positive and negative alcohol expectancies and evaluations: documenting a two-factor structure and within- and between-person variability","volume":"76","author":"Lee","year":"2015","journal-title":"J. Stud. Alcohol. Drugs."},{"issue":"8","key":"10.1016\/j.cct.2025.108189_bb0335","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1080\/13803395.2021.2002269","article-title":"The TestMyBrain digital neuropsychology toolkit: development and psychometric characteristics","volume":"43","author":"Singh","year":"2021","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"5","key":"10.1016\/j.cct.2025.108189_bb0340","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3758\/s13423-012-0296-9","article-title":"Is the Web as good as the lab? Comparable performance from Web and lab in cognitive\/perceptual experiments","volume":"19","author":"Germine","year":"2012","journal-title":"Psychon. Bull Rev."},{"issue":"11","key":"10.1016\/j.cct.2025.108189_bb0345","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of Alcohol Withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)","volume":"84","author":"Sullivan","year":"1989","journal-title":"Br. J. Addict."},{"issue":"9","key":"10.1016\/j.cct.2025.108189_bb0350","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"issue":"s15","key":"10.1016\/j.cct.2025.108189_bb0355","doi-asserted-by":"crossref","first-page":"157","DOI":"10.15288\/jsas.2005.s15.157","article-title":"The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field","author":"Johnson","year":"2005","journal-title":"J. Stud. Alcohol. Suppl."},{"issue":"2","key":"10.1016\/j.cct.2025.108189_bb0360","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopsych.2009.01.029","article-title":"Varenicline reduces alcohol self-administration in heavy-drinking smokers","volume":"66","author":"McKee","year":"2009","journal-title":"Biol. Psychiatry."},{"issue":"4","key":"10.1016\/j.cct.2025.108189_bb0365","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/acer.12669","article-title":"Heterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatment","volume":"39","author":"Litten","year":"2015","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.cct.2025.108189_bb0370","series-title":"Alcoholism: Developing Drugs for Treatment. Guidance for Industry","author":"Food and Drug Administration","year":"2015"},{"issue":"1","key":"10.1016\/j.cct.2025.108189_bb0375","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1088868314542878","article-title":"Statistical approaches for enhancing causal interpretation of the M to Y relation in mediation analysis","volume":"19","author":"MacKinnon","year":"2015","journal-title":"Personality Soc. Psychol. Rev."},{"issue":"1","key":"10.1016\/j.cct.2025.108189_bb0380","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1467-8721.2009.01598.x","article-title":"Current directions in mediation analysis","volume":"18","author":"MacKinnon","year":"2009","journal-title":"Curr. Dir. Psychol. Sci."},{"issue":"9","key":"10.1016\/j.cct.2025.108189_bb0385","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.addbeh.2013.03.018","article-title":"Duration effects in contingency management treatment of methamphetamine disorders","volume":"38","author":"Roll","year":"2013","journal-title":"Addict. Behav."},{"issue":"9","key":"10.1016\/j.cct.2025.108189_bb0390","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.addbeh.2013.03.018","article-title":"Duration effects in contingency management treatment of methamphetamine disorders","volume":"38","author":"Roll","year":"2013","journal-title":"Addict. Behav."},{"issue":"12","key":"10.1016\/j.cct.2025.108189_bb0395","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/add.14409","article-title":"Reaction to \u2018Integrating smoking cessation care in alcohol and other drug treatment settings using an organizational change intervention: a systematic review\u2019 by Skelton et al. (2018)","volume":"113","author":"Van de Graaf","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.cct.2025.108189_bb0400","series-title":"WHO Report on the Global Tobacco Epidemic 2023: Addressing New and Emerging Products","author":"WHO","year":"2021"},{"issue":"3","key":"10.1016\/j.cct.2025.108189_bb0405","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1037\/pha0000252","article-title":"Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers","volume":"27","author":"Green","year":"2019","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"30","key":"10.1016\/j.cct.2025.108189_bb0410","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1523\/JNEUROSCI.2601-10.2010","article-title":"Activation of \u03b14* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption","volume":"30","author":"Hendrickson","year":"2010","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.cct.2025.108189_bb0415","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1177\/1060028014545806","article-title":"Varenicline in the treatment of alcohol use disorders","volume":"48","author":"Erwin","year":"2014","journal-title":"Ann. Pharmacotherapy"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714425003830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714425003830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T11:32:42Z","timestamp":1782041562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714425003830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":83,"alternative-id":["S1551714425003830"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2025.108189","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Pharmaceutically Enhanced Reinforcement for Reduced Alcohol and Smoking (PERRAS) Study: Protocol for a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2025.108189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108189"}}